GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » PS Ratio

Abattis Bioceuticals (Abattis Bioceuticals) PS Ratio : (As of Jun. 01, 2024)


View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Abattis Bioceuticals's share price is $0.0001. Abattis Bioceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2019 was $0.00. Hence, Abattis Bioceuticals's PS Ratio for today is .

The historical rank and industry rank for Abattis Bioceuticals's PS Ratio or its related term are showing as below:

ATTBF's PS Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.17
* Ranked among companies with meaningful PS Ratio only.

Abattis Bioceuticals's Revenue per Sharefor the three months ended in Sep. 2019 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2019 was $0.00.

Back to Basics: PS Ratio


Abattis Bioceuticals PS Ratio Historical Data

The historical data trend for Abattis Bioceuticals's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals PS Ratio Chart

Abattis Bioceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.00 - - - 20.00

Abattis Bioceuticals Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Abattis Bioceuticals's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Abattis Bioceuticals's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abattis Bioceuticals's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abattis Bioceuticals's PS Ratio distribution charts can be found below:

* The bar in red indicates where Abattis Bioceuticals's PS Ratio falls into.



Abattis Bioceuticals PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Abattis Bioceuticals's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.0001/0
=

Abattis Bioceuticals's Share Price of today is $0.0001.
Abattis Bioceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Abattis Bioceuticals  (OTCPK:ATTBF) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Abattis Bioceuticals PS Ratio Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Traded in Other Exchanges
N/A
Address
1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6
Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.

Abattis Bioceuticals (Abattis Bioceuticals) Headlines

From GuruFocus

Abattis Comments on BCSC Temporary Order

By Marketwired Marketwired 11-28-2018

Abattis Provides Marketing and Operational Updates

By Marketwired Marketwired 12-21-2018

Abattis Announces Acquisition of Fertilizer Company NutriVida

By Marketwired Marketwired 12-08-2018

Abattis Announces Share Buy Back Program

By Marketwired Marketwired 08-07-2018

Abattis Provides Update on Conference Call

By Marketwired Marketwired 02-28-2019

Abattis Completes Sale of Northern Vine Interest

By Marketwired Marketwired 08-14-2018

Comfort Launch by Vergence Naturals Exceeds Expectations

By Marketwired Marketwired 12-11-2018